Principles of care for acquired hemophilia
暂无分享,去创建一个
C. Hermans | V. Jiménez‐Yuste | G. Benson | G. Dolan | R. Ljung | E. Santagostino | S. Zupančić šalek | H. Eichler | A. Bowyer | D. Pollard
[1] W. Sperr,et al. Emicizumab for the treatment of acquired hemophilia A. , 2020, Blood.
[2] P. Giangrande,et al. International recommendations on the diagnosis and treatment of acquired hemophilia A , 2020, Haematologica.
[3] Amogh M Joshi,et al. Utilization of Emicizumab in Acquired Factor VIII Deficiency , 2020, The American journal of case reports.
[4] P. Knöbl,et al. Bleeding and Response to Hemostatic Therapy in Acquired Hemophilia A (AHA): Results from the GTH-AH 01/2010 Study. , 2020, Blood.
[5] M. Desborough,et al. Acquired haemophilia A treated with recombinant porcine factor VIII: a single centre UK experience , 2020, British journal of haematology.
[6] C. Königs,et al. Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study , 2020, Journal of thrombosis and haemostasis : JTH.
[7] P. Giangrande,et al. Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement , 2019, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] Ammar Eljack,et al. Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report , 2019, The American journal of case reports.
[9] M. Streiff,et al. Successful use of emicizumab in a patient with refractory acquired hemophilia A and acute coronary syndrome requiring percutaneous coronary intervention , 2019, Research and practice in thrombosis and haemostasis.
[10] M. Spannagl,et al. Emicizumab in the Treatment of Acquired Haemophilia: A Case Report , 2019, Transfusion Medicine and Hemotherapy.
[11] P. Knöbl. Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A , 2018, Drugs.
[12] S. Nair,et al. Principles of haemophilia care: The Asia‐Pacific perspective , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[13] O. Christophe,et al. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? , 2017, Blood.
[14] C. Leissinger,et al. Acquired hemophilia A: Updated review of evidence and treatment guidance , 2017, American journal of hematology.
[15] 2017 Clinical trials update: Innovations in hemophilia therapy , 2017, American journal of hematology.
[16] K. Gomez,et al. Use of an innovative syringe pump to deliver bolus rFVIIa for patients with haemophilia and inhibitors undergoing surgery , 2017 .
[17] M. Sholzberg,et al. Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[18] C. Kessler,et al. Acquired haemophilia: an overview for clinical practice , 2015, European journal of haematology.
[19] C. Leissinger,et al. Acquired hemophilia A: emerging treatment options , 2015, Journal of blood medicine.
[20] E. Gomperts,et al. Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.
[21] R. Greil,et al. Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study. , 2015, Blood.
[22] A. Tiede,et al. Laboratory Diagnosis of Acquired Hemophilia A: Limitations, Consequences, and Challenges , 2014, Seminars in Thrombosis & Hemostasis.
[23] S. Araf,et al. An unusual cause of a haemorrhagic stroke: acquired haemophilia A , 2013, BMJ Case Reports.
[24] J. Goudemand,et al. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[25] M. Makris,et al. The World Federation of Hemophilia guideline on management of haemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] J. Mahlangu,et al. Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[27] H. Schwarz,et al. Factor Eight Inhibitor Bypassing Activity , 2012 .
[28] D. Cooper,et al. Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey , 2012, Journal of multidisciplinary healthcare.
[29] F. Pellegrini,et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). , 2012, Blood.
[30] F. Pellegrini,et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. , 2012, Blood.
[31] J. Esser,et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) , 2012, Journal of thrombosis and haemostasis : JTH.
[32] P. Collins,et al. Management of acquired haemophilia A , 2011, Journal of thrombosis and haemostasis : JTH.
[33] C. Kessler,et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A , 2010, BMC Research Notes.
[34] J. Oldenburg,et al. Genetic markers in acquired haemophilia , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[35] P. Collins,et al. Advances in the understanding of acquired haemophilia A: implications for clinical practice , 2010, British journal of haematology.
[36] C. Kessler,et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A , 2009, Haematologica.
[37] S. Seremetis,et al. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.
[38] T. Baglin,et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. , 2007, Blood.
[39] J. Astermark,et al. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. , 2007, Blood.
[40] G. Mariani,et al. Acquired hemophilia A: A concise review , 2005, American journal of hematology.
[41] S. Sallah. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.
[42] J. Delgado,et al. Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors , 2003, British journal of haematology.
[43] C. Négrier,et al. The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre Study , 1997, Thrombosis and Haemostasis.
[44] A. Rademaker,et al. A Prospective, Randomized Trial of Prednisone and Cyclophosphamide in the Treatment of Patients with Factor VIII Autoantibodies , 1993, Thrombosis and Haemostasis.
[45] C. Kitchens,et al. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. , 1987, Archives of internal medicine.